Escaping the Technology Spend Trap to Enable Real Law Firm Growth: InOutsource Highlighted on "All Access hosted by Andy Garcia"

LOS ANGELES, Sept. 22, 2026 /PRNewswire/ -- Wrestling with escalating software costs — that have been accelerated by insatiable hunger for AI tools —and extensive professional compliance requirements, law firms know they must evolve. They are seeking practical approaches to harnessing their unique IP, greater insight into practice and business operations, and new strategies to enable profitable growth.

Driven by snowballing expenses associated with AI adoption, law firm technology budgets continue to inflate dramatically. Yet firm leadership often struggles to demonstrate a clear return on major software investments. To address this disconnect, "All Access hosted by Andy Garcia" will feature a special segment examining how InOutsource enables organizations to more effectively connect technology adoption with business profitability. Airing on Public Television in key legal markets across the United States, the segment highlights how modernized data architecture, automated workflow, and enhanced analytics enables organizations to more effectively adopt AI, enhance business development, and improve client service.

The program illustrates how ad hoc approaches to addressing critical data and information management challenges expose firms to compliance risks, while obscuring valuable commercial opportunities. InOutsource helps law firms modernize their data estate, creating structured environments where information can be safely harnessed in the age of AI.

By aligning business development, client due diligence, and compliance with today's professional standards, InOutsource provides firms with the clarity to reduce vendor costs, protect client information, and unlock new levels of business insight and execution.

"The accelerating growth of AI is forcing law firms to rethink everything—from the way clients are engaged, to how service is delivered, to how the entire business runs. We're excited to share our perspective with the viewers of All-Access with Andy Garcia on how an integrated approach to data governance, workflow execution, and risk management enables organizations to thrive in this new environment." – Nancy Beauchemin, CEO and Founder , InOutsource.

About "All Access hosted by Andy Garcia": "All Access hosted by Andy Garcia" is an educational Public Television series produced to inform viewers on critical topics shaping modern society, business, and technology. Through compelling short-form documentary segments, the program highlights forward-thinking organizations, industry leaders, and technical innovations that drive meaningful progress across various sectors. To learn more about the program and view upcoming broadcast schedules, visit allaccessptv.com.

About InOutsource: InOutsource is an independent consultancy dedicated to helping law firms modernize information governance, enhance risk management, and drive measurable ROI from technology investments. With decades of industry experience, the company provides strategic consulting, data security, and specialized software solutions that enhance client development, streamline client intake, and simplify legal business operations. For additional information about services and insights, visit www.inoutsource.com.

SOURCE All Access

Share this article

TORONTO, Sept. 22, 2026 /PRNewswire/ -- Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV1) is pleased to provide the first assays of extensional deep drilling of assay results from its Summer 2026 drill program. Prior to the summer drill program drilling concentrated on improving the density of drill intercepts for the recently announced MRE to increase the confidence of modelling Lion, particularly within the range of a potential future open pit, and to bring the vast majority of the known deposit as of the end of the winter program (end April 2026) to Drill Indicated category.

For the summer drill program Power Metallic has carried out widely spaced exploration drilling on geological and geophysical (EM) targets and more importantly begun a program of extending the Lion deposit to depth below the outline of the MRE model. The two holes reported here are the first assays to be completed on this deep drilling.

Hole PML-26-125 is the deepest assay results to date at Lion at a vertical depth of nearly 800m vertical depth, well below the current MRE. Prior to Hole PML-26-125 The deepest reported hole intersecting the core of the Lion shoot to date (PML-25-002) intersected 1.95 metres at 7.95% CuEqRec* at approximately 610 metres vertical depth. This hole was targeted on the projected center of the Lion plunge approximately 150m below the previous deepest hole and intersected 5.7m of massive to semi-massive copper sulphides (Table 1). An earlier drill hole, PML-26-121a targeted the western side of the projected plunge of Lion at a vertical depth of nearly 650 meters and intersected disseminated to semi-massive copper sulphides. A subsequent hole (PML-26-128) tested the eastern side of the interpreted Lion plunge at nearly 900 meters vertical depth, showing disseminated and massive veinlets of copper sulphides, with assays pending (Figure 1). All three of these holes firmly established that the Lion deposit continues at depth and has not been fully delineated.

Power Metallic is expecting more assay results from the Lion deep drilling and regional exploration in the weeks to come.

Terry Lynch, CEO of Power Metallic, commented:

We are in the unique position due to the high grade and near surface nature of our project to advance development of what the world needs in Critical Minerals, namely Copper and PGEs, but also continue our multifaceted exploration approach to allow the resource to grow substantially between now and the end of 2027. Today's results pushed us over 25% deeper than the deepest hole used in our recently announced MRE and it did so with significantly higher grades. We have visibility down over 50% deeper and visibly it looks like we are still in the Lion Zone. As we have seen with the great hit Talon Metals recently had deposits can get thicker and richer at depth. The blessing in Lion is our mineralization starts at surface and extends down making it very economic to mine and explore. We are excited to get back to exploration!

Qualified Person

Joseph Campbell, P. Geo, VP Exploration at Power Metallic, is the qualified person who has reviewed and approved the technical disclosure contained in this news release.

About Power Metallic Mines Inc.

Power Metallic is a Canadian exploration company focused on advancing the Nisk Project Area (Nisk–Lion–Tiger)—a high–grade Copper–PGE, Nickel, gold and silver system—toward Canada's next polymetallic mine.

On 1 February 2021, Power Metallic (then Chilean Metals) secured an option to earn up to 80% of the Nisk project from Critical Elements Lithium Corp. (TSX–V: CRE). Following the June 2025 purchase of 313 adjoining claims (~167 km²) from Li–FT Power, the Company now controls ~330 km² and roughly 50 km of prospective basin margins.

Power Metallic is expanding mineralization at the Nisk and Lion discovery zones, evaluating the Tiger target, and exploring the enlarged land package through successive drill programs. Beyond the Nisk Project Area, Power Metallic indirectly has an interest in significant land packages in British Columbia and Chile, by its 50% share ownership position in Chilean Metals Inc., which were spun out from Power Metallic via a plan of arrangement on February 3, 2025.

It also owns 100% of Power Metallic Arabia which owns 100% interest in the Jabul Baudan exploration license in The Kingdon of Saudi Arabia's Jabal Said Belt. The property encompasses over 200 square kilometres in an area recognized for its high prospectivity for copper gold and zinc mineralization. The region is known for its massive volcanic sulfide (VMS) deposits, including the world-class Jabal Sayid mine and the promising Umm and Damad deposit.

For further information, readers are encouraged to contact:

Power Metallic Mines Inc.

The Canadian Venture Building

82 Richmond St East, Suite 202

Toronto, ON

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

QAQC and Sampling

GeoVector Management Inc ("GeoVector") is the Consulting company retained to perform the actual drilling program, which includes core logging and sampling of the drill core.

All core in this news release is either HQ or NQ sized core. Drill core is re-fitted and measured. Geotech on core includes photographs (wet & dry), rock quality index, magnetic susceptibility, conductivity, and recovery estimates. Core is logged for lithology, mineralogy, and structural features, and sample intervals are delineated and tagged.

Sampled core is mechanically sawn, and half-core is retained for future reference. GeoVector's QAQC program includes regular insertion of CRM standards, duplicates, and blanks into the sample stream with a stringent review of all results. QAQC and data validation was performed, and no material errors were observed.

All samples were submitted to and analyzed at Activation Laboratories Ltd ("Actlabs"), a commercial laboratory independent of Power Metallic with no interest in the Project. Actlabs is an ISO 9001 and 17025 certified and accredited laboratories. Samples submitted through Actlabs are run through standard preparation methods and analysed using RX-1 (Dry, crush ( 7 kg) up to 80% passing 2 mm, riffle split (250 g) and pulverize (mild steel) to 95% passing 105 μm) preparation methods, and using 1F2 (ICP-OES) and 1C-OES - 4-Acid near total digestion + Gold-Platinum-Palladium analysis and 8-Peroxide ICP-OES, for regular and over detection limit analysis. Pegmatite samples are analyzed using UT7 - Li up to 5%, Rb up to 2% method. Actlabs also undertake their own internal coarse and pulp duplicate analysis to ensure proper sample preparation and equipment calibration.

Cautionary Note Regarding Forward-Looking Statements

This message contains certain statements that may be deemed "forward-looking statements" concerning the Company within the meaning of applicable securities laws. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," "indicates," "opportunity," "possible" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, are subject to risks and uncertainties, and actual results or realities may differ materially from those in the forward-looking statements. Such material risks and uncertainties include, but are not limited to, among others; the timing for various drilling plans; the ability to raise sufficient capital to fund its obligations under its property agreements going forward and conduct drilling and exploration; to maintain its mineral tenures and concessions in good standing; to explore and develop its projects; changes in economic conditions or financial markets; the inherent hazards associates with mineral exploration and mining operations; future prices of nickel and other metals; changes in general economic conditions; accuracy of mineral resource and reserve estimates; the potential for new discoveries; the ability of the Company to obtain the necessary permits and consents required to explore, drill and develop the projects and if accepted, to obtain such licenses and approvals in a timely fashion relative to the Company's plans and business objectives for the applicable project; the general ability of the Company to monetize its mineral resources; and changes in environmental and other laws or regulations that could have an impact on the Company's operations, compliance with environmental laws and regulations, dependence on key management personnel and general competition in the mining industry.

SOURCE Power Metallic Mines Inc.

Share this article

Corvex Management requisitions general meeting to elect James Gemmel to the board of Whitbread PLC

After a year spent seeking a constructive path with the Board, Corvex is requisitioning a general meeting to appoint James Gemmel as a direct shareholder voice in the boardroom

Corvex comes with no predetermined agenda and is not demanding a sale of the company - only a rigorous, fact-based review of every strategic alternative available to Whitbread

James Gemmel has 15 years of experience engaging with public company boards and management helping shareholders unlock value

LONDON, Sept. 22, 2026 /PRNewswire/ -- Corvex Management LP ("Corvex"), on behalf of funds advised by it, today delivered a notice to the Board of Directors of Whitbread PLC ("Whitbread" or the "Company") requesting that it convene a general meeting of shareholders for the purpose of electing James Gemmel, a Partner at Corvex, to Whitbread's Board of Directors.

Corvex has been a shareholder in Whitbread since 2024, currently holds c. 6.4% of Whitbread's ordinary shares and has an economic interest (including such shares) in Whitbread representing approximately 7% of total shares outstanding, which it believes makes it Whitbread's largest active shareholder. It believes the Company is anchored by a unique and valuable collection of assets, including the iconic, market-leading Premier Inn brand. However, over the past decade Whitbread has delivered negative total shareholder returns and has materially underperformed its peers and the wider market on a one, three, five and ten year time horizon and the Company is currently trading at a significantly discounted multiple to its peers. In Corvex's view, the Board's recent strategy review failed to address Whitbread's underlying challenges and was poorly received by the market.

Corvex is not seeking control of Whitbread and is not demanding a sale of the Company. It is asking for a single seat on the Board, which currently has very limited shareholder alignment, to work in a collegiate and constructive manner, with no predetermined agenda, to benchmark the Company's current strategy, which has failed to deliver value for shareholders, against every credible alternative to establish a pathway that maximises value for all.

The letter, together with a presentation of supplemental materials, is available at www.unlockingwhitbread.com.

The full text of the letter follows:

September 22, 2026

To the Board of Directors, and Shareholders, of Whitbread PLC:

Today we delivered a notice to the Company requesting that it schedule a general shareholder meeting for the purpose of electing James Gemmel, a Partner at Corvex, to Whitbread's Board of Directors. James has been with Corvex since our launch in 2011 and has spent the past fifteen years conducting deep fundamental research on, and investing in, companies like Whitbread: businesses with strong fundamentals that have underperformed and are going through a period of change. Throughout, he has worked with boards and management teams to create value for all shareholders.

We have been investors in Whitbread since 2024 and currently hold c. 6.4% of Whitbread's ordinary shares and have an economic interest (including such shares) in Whitbread representing approximately 7% of total shares outstanding, which we believe makes us Whitbread's largest active shareholder. Our thesis remains largely unchanged since our initial investment: Whitbread is a unique collection of assets anchored by the iconic Premier Inn brand with a leading market position. What has changed is our growing concern with the Company's strategic direction, continued commitment to the status quo, and, in particular, the structural complexity of the business and its approach to capital allocation.

Over the past year, we have repeatedly raised these concerns with the Company and made clear our desire to work constructively with the Board, including through direct Board representation. We had hoped to reach a mutually agreeable path forward through private engagement, but the Company's limited willingness to meaningfully engage has ultimately left us with little choice but to take the action we are announcing today.

Since the sale of Costa in 2018, Whitbread has deployed ~£2.6bn of growth CapEx while delivering only ~3% EPS CAGR, a flat dividend and a ~£2.3bn increase in lease-adjusted net debt. The consequences are clear: shareholders have suffered negative total returns of approximately (17%) over the past ten years, (18%) over the past five years and (22%) over the past year, materially underperforming comparable companies and relevant indices.

We believe a fresh perspective is warranted. With the Company committing to a further ~£2.5bn of gross CapEx over the next five years, funded by ~£1.5bn of sale-leaseback financing, a commitment of this scale requires direct shareholder representation on the Board - certainly more than the ~0.04% of shares currently owned by the Board. Corvex has spent fifteen years working with boards through exactly these kinds of strategic inflection points, with members of our team having served on more than a dozen public company boards, particularly across hospitality and consumer businesses.

We intend to join this Board with no preconceived notions and no predetermined agenda - only a commitment to maximizing risk-adjusted value for all shareholders. We are not seeking control, nor are we demanding a sale of the Company. Our priority would be to fully understand the rationale, assumptions and expected returns underpinning the Company's current capital plan, and then rigorously benchmark that plan against every credible strategic, structural and operational alternative. We want the facts to determine the best path forward.

We are not looking to criticize individual directors. We want to work with the Board in a collegiate and non-adversarial way, as one member among many, bringing a direct shareholder perspective to these decisions. With no constraint on our investment horizon, we intend to act as a long-term owner. Having sought a constructive path with the Company over the past year, we are now simply exercising the rights afforded to us as a 5%+ shareholder under UK law.

James Gemmel has done this before - working constructively with incumbent boards while helping deliver meaningful value for shareholders. As a Non-Executive Director of Kindred Group and Chair of its Audit Committee, James helped steer the business through a period of significant strategic change. The Board appointed a new CEO, exited North America to refocus capital on core markets, and restored Kindred's leadership position in the newly regulated Dutch market. Following a strategic review, James led negotiations with FDJ's Chairwoman and CEO, resulting in a recommended all-cash acquisition at a 35% premium to the 30-day average share price.

Following James' appointment to the Board of MDU Resources, the company delivered a step change in profitability across all three businesses. A strategic review led to two spin-offs, a sharpened focus on improving returns in the regulated utility business, and substantial margin expansion at construction materials subsidiary Knife River. Together, these actions generated a 140% return for shareholders.

Whitbread's share price today does not reflect the value of the underlying assets; the Board's decisions over the next five years will. We therefore ask for your support in appointing James Gemmel to the Board as a mandate to evaluate change, ensuring shareholders have a direct voice in the room as those critical decisions are made.

Respectfully,

Keith Meister

Managing Partner

Corvex Management LP

SOURCE Corvex Management

Share this article

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

- RINVOQ is now approved in the European Union for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients two years of age and older who have responded inadequately to, or who are intolerant to, one or more DMARDs1

- Approval was based on the open-label Phase 1 SELECT-YOUTH study and data from adults with rheumatoid arthritis1,2

- A new oral solution of RINVOQ was approved for use in patients with pJIA1

- RINVOQ is currently approved in the European Union for 11 indications across various immune-mediated, inflammatory diseases1

NORTH CHICAGO, Ill., Sept. 22, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Commission (EC) has approved RINVOQ® (upadacitinib; 15 mg tablet and weight-based 1 mg/mL oral solution) for the treatment of active polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [RF+] or negative [RF-], extended oligoarticular), in patients two years of age and older who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate.1

"The European Commission's approval of RINVOQ for pJIA expands the treatment options available to pediatric patients and their families, offering the potential for remission, improvements in pain and physical function," said Roopal Thakkar, M.D., executive vice president, research and development, chief scientific officer, AbbVie. "RINVOQ's new indication continues to build on our differentiated immunology portfolio with breadth and depth across therapeutic areas and patient populations."

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood and is estimated to impact approximately 126,000 children in Europe.3 pJIA is a subtype of JIA and is characterized by inflammation in five or more joints – including the small joints of the hands and feet and large joints like the knees, hips and ankles – that persists for at least six weeks in children and adolescents.4,5 This disease can be painful and debilitating and, if left untreated, may lead to joint damage.3,6 Ongoing disease activity in pJIA is common, with persistent symptoms or flares affecting many patients into adulthood.6-8

Data Supporting the EC Approval

The EC approval of RINVOQ for pJIA is supported by the SELECT-YOUTH study and data from adult patients with rheumatoid arthritis. The SELECT-YOUTH study is a single-arm, open-label, global, Phase 1 study evaluating the pharmacokinetics, efficacy, safety and tolerability of RINVOQ in patients ages 2 to 18 years.1,2

RINVOQ demonstrated efficacy as early as week 12, with response rates improving through week 48, as shown below.1,2 The efficacy observed in children with pJIA was generally consistent with responses in adult patients with rheumatoid arthritis.1

Functional ability, as measured by C-HAQ, improved, with a mean change from baseline of −0.46 (n=115) at week 12 and −0.64 (n=108) at week 48. Pain scores also improved, with a mean change from baseline of −26.2 (n=116) at week 12 and −30.8 (n=109) at week 48. C-HAQ and pain data are reported as observed.2

In the study, no new safety risks were identified.9 The rate of treatment-emergent adverse events (TEAEs) was 499.6 events per 100 patient-years (E/100 PY). The rate of serious adverse events was 10.2 E/100 PY. The rate of TEAEs that led to discontinuation of the study drug was 2.7 E/100 PY. No cases of major cardiovascular or thrombotic events, malignancies or deaths were reported during the study period.2 No negative impact on growth or development was observed.9

"The SELECT-YOUTH results underscore that clinical remission for children with pJIA is not a rare hope but a critical and achievable outcome that helps reduce the risk of permanent joint damage in some of our youngest, most vulnerable patients," said Prof. Dr. Gerd Horneff, head of the Department of General Pediatrics, Asklepios Clinic, Sankt Augustin, Germany. "The approval of RINVOQ in active pJIA provides a new oral systemic treatment option for patients suffering from this often-debilitating condition."

RINVOQ is also approved in the European Union for the treatment of adults and adolescents with atopic dermatitis, non-segmental vitiligo and alopecia areata and for adults with radiographic axial spondyloarthritis, non-radiographic axial spondyloarthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, Crohn's disease and giant cell arteritis.1

About the SELECT-YOUTH Study

The SELECT-YOUTH (M15-340) study is a single-arm, open-label, global, Phase 1 study to evaluate the pharmacokinetics, efficacy, safety and tolerability of upadacitinib in patients with polyarticular course juvenile idiopathic arthritis (pcJIA), ages 2 to 18 years. This study consists of three parts: Part 1 consisted of a seven-day multiple-dose pharmacokinetic evaluation, after which patients in Parts 2 and 3 of the trial received a low dose of upadacitinib (equivalent to 15 mg) by using either a twice-daily oral solution or once-daily extended-release tablet based on their body weight and ability to swallow tablets. For more detailed information on this study, please visit clinicaltrials.gov (NCT03725007).

About RINVOQ® (upadacitinib)

Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases.1,10 In human cellular assays, RINVOQ preferentially inhibits signaling by JAK1 or JAK 1/3 with functional selectivity over cytokine receptors that signal via pairs of JAK2.1

Upadacitinib (RINVOQ) is being studied in Phase 3 clinical trials for hidradenitis suppurativa, Takayasu arteritis and systemic lupus erythematosus and in pediatric studies for systemic juvenile idiopathic arthritis, atopic dermatitis, ulcerative colitis and Crohn's disease.

EU Indications and Important Safety Information about RINVOQ® (upadacitinib)1

Indications

Rheumatoid arthritis

RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate.

Psoriatic arthritis

RINVOQ is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate.

Polyarticular juvenile idiopathic arthritis

RINVOQ is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [RF+] or negative [RF-], extended oligoarticular), in patients 2 years of age and older who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate.

Axial spondyloarthritis

Non-radiographic axial spondyloarthritis (nr-axSpA)

RINVOQ is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).

Ankylosing spondylitis (AS, radiographic axial spondyloarthritis)

RINVOQ is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy.

Giant cell arteritis

RINVOQ is indicated for the treatment of giant cell arteritis (GCA) in adult patients.

Atopic dermatitis

RINVOQ is indicated for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents 12 years and older who are candidates for systemic therapy.

Alopecia areata

RINVOQ is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

Vitiligo

RINVOQ is indicated for the treatment of non-segmental vitiligo in adults and adolescents 12 years and older who are candidates for systemic therapy.

Ulcerative colitis

RINVOQ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Crohn's disease

RINVOQ is indicated for the treatment of adult patients with moderately to severely active Crohn's disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Important Safety Information

Contraindications

RINVOQ is contraindicated in patients hypersensitive to the active substance or to any of the excipients, in patients with active tuberculosis (TB) or active serious infections, in patients with severe hepatic impairment, and during pregnancy.

Special warnings and precautions for use

RINVOQ should only be used if no suitable treatment alternatives are available in patients:

- 65 years of age and older;

- patients with history of atherosclerotic cardiovascular (CV) disease or other CV risk factors (such as current or past long-time smokers);

- patients with malignancy risk factors (e.g. current malignancy or history of malignancy)

Use in patients 65 years of age and older

Considering the increased risk of MACE, malignancies, serious infections, and all-cause mortality in patients ≥65 years of age, as observed in a large randomised study of tofacitinib (another Janus Kinase (JAK) inhibitor), RINVOQ should only be used in these patients if no suitable treatment alternatives are available.

Hylenr Completes Phase 1 LCF Reactor Validation at Texas A&M University

Phase 1 testing identified key thermal, noble-gas and material signatures in the Lattice Confinement Fusion (LCF) reactor, with Hylenr now advancing to Phase 2 studies focused on reproducibility, quantitative measurement and commercialization.

HYDERABAD, India, Sept. 22, 2026 /PRNewswire/ -- Hyderabad based Deeptech company Hylenr today announced the completion of Phase 1 of an independent validation study of Lattice Confinement Fusion (LCF), conducted at Texas A&M University, marking an important step in the company's efforts to independently evaluate its lattice-based energy technology and advance its roadmap toward commercialization.

The validation study focused on the Hylenr BRT-NiUCS-2 reactor, a small modular system based on hydrogen-loaded nickel-palladium catalyst materials. Multiple devices and catalyst samples were prepared and tested under controlled laboratory conditions in the Nuclear Engineering Department at Texas A&M University.

Titled 'Validation of Anomalous Heat and Nuclear Signatures in the BRT-NiUCS-2 Reactor: Phase 1 LCF Investigation', the research examined the reactor's thermal performance, radiation emissions, residual gas composition, and post-reaction material characteristics. The Phase 1 research paper, co-authored by Hylenr and Texas A&M University, was presented at the 27th International Conference on Condensed Matter Nuclear Science (ICCF-27), held in Niagara Falls, Canada, from August 31 to September 4.

"Our objective has always been to move beyond internal observations and subject the technology to rigorous, independent testing. The validation study conducted at Texas A&M University provides an important external data point across thermal measurements, gas analysis, and material characterization," said Ram Ramaseshan, Co-Founder and CEO, Hylenr. "These results provide a basis for the next phase of validation while reinforcing our focus on reproducibility, quantitative measurement, and scientific transparency."

Prof. Lin Shao, Professor of Nuclear Engineering at Texas A&M University said, "The Phase 1 research provided an opportunity to examine the BRT-NiUCS-2 reactor using a range of complementary analytical techniques. The combination of thermal measurements, residual gas analysis, nuclear diagnostics and post-reaction materials characterization broadens the experimental basis for assessing the observed phenomena and determining priorities for further investigation."

Among the principal diagnostics was Residual Gas Analysis (RGA), conducted using an SRS RGA 100 system under high-vacuum conditions. The study observed elevated helium, argon and neon signals in the active reactor relative to background measurements, with helium and argon signals reported at levels approximately two to three orders of magnitude above background. No corresponding increase in nitrogen was observed, providing evidence against atmospheric leakage as the sole explanation for the measurements.

Thermal measurements using thermocouples and calibrated infrared imaging also showed the active reactor operating at consistently higher temperatures than the calibration device under comparable input-power conditions. The study further reported post-reaction morphological and compositional changes in catalyst samples based on SEM/EDX analysis.

Radiation monitoring using Geiger–Müller and neutron detectors found no detectable gamma or X-ray emissions, while neutron counts remained statistically indistinguishable from background during the approximately five-day monitoring period.

Hylenr will now move toward Phase 2, focusing on testing multiple independent reactors, quantitative calorimetry and improved characterization of loading parameters, alongside isotopic-ratio measurements and advanced analytical techniques including SIMS and ICP-MS.

The company views this staged validation process as a critical bridge between laboratory observations and eventual commercialization, with future development aimed at establishing repeatability, quantifying energy output and defining the engineering requirements for scalable systems.

About Hylenr

Hylenr develops small, modular energy systems using hydrogen-loaded materials and lattice confinement. Its research focuses on material transformation and excess-heat phenomena under controlled conditions, progressing these findings through independent validation toward potential commercial energy applications.

SOURCE HYLENR

Share this article

Temu Strengthens Support for Romanian Businesses in Collaboration with ABSL

BUCHAREST, Romania, Sept. 22, 2026 /PRNewswire/ -- Temu has signed a Memorandum of Understanding (MoU) with the Association of Business Service Leaders in Romania (ABSL), the country's leading organization representing the business services sector.

The partnership will see Temu take part in ABSL's programs and events, engaging directly with ABSL's community, a network spanning startups to multinational companies operating in shared services, business process outsourcing, IT outsourcing, and R&D.

Temu will also contribute expertise and in-kind support to ABSL's initiatives, reflecting Temu's commitment to becoming a trusted, active participant in Romania's business ecosystem.

"We welcome Temu as an ABSL E-commerce Partner. This collaboration reflects the growing importance of cross-sector cooperation and creates new opportunities to connect expertise from the business services and e-commerce sectors," said Adrian Baron, President of ABSL Romania. "It also provides a valuable platform for dialogue and the exchange of perspectives, supporting the continued development of the broader business community in Romania."

This collaboration aligns with Temu's broader efforts to support local businesses in Europe and address key barriers to growth like complexity, cost, and lack of connection cited by trade associations, chambers of commerce, and industry bodies during discussions with Temu this year.

"Romania has a vibrant business community and we want to help them grow," said a Temu spokesperson. "Through the collaboration with ABSL, we hope to contribute to the business ecosystem in Romania."

Businesses interested in selling on Temu can apply through the seller portal at seller.temu.com.

About Temu

Temu is a global e-commerce platform connecting consumers with millions of manufacturers, brands and business partners. Operating in more than 90 markets worldwide, Temu is committed to providing affordable, high-quality products that enable customers to live better lives.

About ABSL

The Association of Business Service Leaders in Romania (ABSL) is a leading organization representing the business services sector in Romania, gathering high profile companies which conduct business in the area of Shared Services Center (SSC), Business Process Outsourcing (BPO), Information Technology Outsourcing (ITO), Research and Development (R&D) and companies contributing to the sector's growth.

The Association pursues its objectives by fostering collaboration within the sector, conducting industry research, promoting both the industry and the opportunities Romania has to offer, and working closely with public authorities to support the sector's continued development.

ABSL Romania's activities are structured around several key areas: organizing best-practice sharing and networking events, developing industry studies and practical guides, promoting Romania as an investment destination, delivering educational initiatives, and engaging in government relations.

ABSL Romania's community brings together both Romanian and multinational companies, including regional and global leaders in the business services industry.

Share this article

Panel to be Moderated by Sabio Advisor Caleb Pearson, Featuring McDonald's Global Media Lead Michelle Niblock

LOS ANGELES, Sept. 22, 2026 /PRNewswire/ -- Creator TV®, the first creator-led streaming network and content studio owned by Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF), today announced that Co-Founder and General Manager Joe Ochoa will join a panel at Marketecture Live on September 23 in Chicago to discuss how sports fandom is changing, the evolving roles of creators, and what it means for the brands trying to reach these audiences.

The session, "Sports Influence Looks Different Now: Where Creators and Fandom Meet," is scheduled as a breakout at 1:45 p.m. CT. The panel will be moderated by Caleb Pearson, Advisor to Sabio Holdings with over 20 years of marketing and media leadership experience, including his time as Vice President at McDonald's, where he led Media, CRM, Loyalty, Digital, and Customer Experience. His prior leadership roles include Grubhub and Citi. Michelle Niblock, McDonald's Global Media Lead and US Digital Lead at Publicis Groupe, will also be joining the panel.

Sports fandom has fundamentally changed. Creators, athletes, social media and the data behind it all have made it personal, year-round and always on, driving growth well beyond the broadcast alone. The session will explore how brands are adapting their media strategies as audiences move fluidly between live broadcasts, streaming platforms and creator content, and why the biggest opportunities often exist beyond traditional sports media.

"We've seen firsthand what happens when you put creators at the center of a live sports moment," said Joe Ochoa, Co-Founder and General Manager at Creator TV®. "People don't just watch, they show up and stay engaged long after the event ends. This is what real community building looks like, and it's something brands should be paying attention to."

Ochoa's appearance follows a string of live moments for Creator TV Sports™, including the debut of the Creator Pickleball Tour at VidCon Anaheim earlier this year, as the company continues to build out its live, creator-driven sports programming.

This panel comes as Creator TV continues to experience rapid growth. The platform's audience is up 4.8x year to date, from January through August 2026, and hit 305,000 unique viewers in August, marking a new record high. Average monthly audience is also up 138% in 2026 compared to 2025. According to an audience analysis from Sabio's App Science®, Creator TV viewers are 2.5x more likely to stream sports content, underscoring the crossover between creator audiences and sports fandom the panel will explore.

Marketecture Live brings together marketing, media and advertising leaders for a day of programming on where the industry is headed. More information on the event is available at https://chicago.marketecturelive.com.

About Creator TV®

Creator TV® is a creator-led entertainment company operating at the intersection of the creator economy, television, and advertising. We build live, in-person, and digital experiences that turn shared passions into real community, bringing creators and audiences together around the moments shaping culture today. Our content studio develops and produces original formats and franchises distributed across major streaming TV and social platforms. For brands, Creator TV offers authentic ways to engage those communities through content, live experiences, CTV advertising, and creator marketing. Distributed across Plex, Xumo Play, Amazon Fire TV Channels and more, Creator TV® is headquartered in Los Angeles and owned and operated by Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF), an award-winning leader in connected television advertising technology. Learn more at creatortv.com.

About Sabio

Sabio Holdings (TSXV: SBIO, OTCQB: SABOF) is a technology and services leader in the fast-growing ad-supported streaming space. Its cloud-based, end-to-end technology stack works with top blue-chip, global brands and the agencies that represent them to reach, engage, and validate (R.E.V.) streaming audiences. Sabio consists of a proprietary ad-serving technology platform, App Science™, a non-cookie-based SaaS analytics and insights platform with AI natural language capabilities, and Creator TV®, the first creator-led streaming network and content studio. For more information, visit sabioctv.com.

Contact:

Investor Relations

Sajid Premji, Chief Financial Officer, [email protected], 1.844.974.2662 

SOURCE Sabio Inc.

Share this article

GOTHENBURG, Sweden and SUNNYVALE, Calif., Sept. 22, 2026 /PRNewswire/ -- Accenture (NYSE: ACN) and Google Cloud today announced that Volvo Cars has become the lead industry partner for Horizon, an open-source software development platform that helps car makers and automotive suppliers build, test, and deploy software for Android Automotive Operating System (AAOS) more efficiently.

Horizon brings together cloud-native development tools, virtual testing environments, and AI-assisted workflows into a unified platform. This helps car makers and automotive suppliers develop and deliver high-quality software at speed and make engineering more productive.

As Horizon's lead industry partner, Volvo Cars is migrating its global AAOS software development environment to the Horizon platform. The platform will give its engineers access to faster development workflows, virtual testing environments and AI-assisted software development tools, freeing engineering teams to spend more time building in-car experiences.

"We're building some of the most complex products in the world, which requires a development environment built to match," said Gregor Zetsche, Head of Connected Experience at Volvo Cars. "As Horizon's lead industry partner, we can directly solve our toughest engineering challenges and empower our teams to deliver new experiences faster than ever."

Volvo Cars is the lead car maker working with Accenture and Google Cloud to bring the Horizon platform to the industry. Insights from this collaboration will help refine the platform and expand its generative AI capabilities for automotive companies and other industrial manufacturers.

Accelerating connected software development

Modern vehicles increasingly offer digital experiences, such as navigation, media, voice assistants, connected services and over-the-air software updates. As consumers expect these experiences to become richer and more sophisticated throughout a vehicle's lifetime, manufacturers need faster and more efficient ways to build, test, and validate the software that enables improvements at scale.

For car makers and the wider automotive industry, the Horizon platform addresses these challenges by offering:

- An up to 9x faster software testing using virtual Cuttlefish-based Android Automotive environments, that enable large-scale testing with agentic AI.

- A reduction of infotainment feature development costs by up to 40%.

- Intelligent caching and optimized build pipelines significantly reduce software build times: Instead of waiting up to two hours, engineers can get feedback within minutes.

- Remote access to virtual and physical device farms allows developers worldwide to build and validate software from anywhere, while reducing infrastructure requirements. This improves hardware utilization and reduces the amount of costly physical test equipment required.

- Virtual workbenches are speeding up the onboarding of new developers. Instead of waiting weeks for physical specialized hardware and investing additional hours for the setup, engineers can instantiate their environments in seconds.

"Horizon enables a faster, more flexible and efficient way to deliver software-defined vehicle features. Its standardized, repeatable and scalable processes help deliver reliable, high-quality software products, while significantly reducing time to market," said Juergen Reers, Global Automotive & Mobility Lead, Accenture. "Horizon will allow Volvo Cars' engineers to focus on what matters most: creating differentiated vehicle experiences and continuously delivering new value to drivers through software at high speed."

"Software now defines the automotive brand," said Henry Bzeih, Global Director, Automotive Industry, Google Cloud. "Horizon on Google Cloud gives Volvo Cars the ability to move faster while releasing high-quality software and features on a cadence that matches the expectations of modern mobility. This is how next generation digital experiences reach drivers at agile speed."

Accenture and Google Cloud, with Volvo Cars as leading industry partner, are already working with other automotive and industrial organizations to extend the reach of Horizon into further companies and markets.

About Accenture

Accenture helps the world's leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed for organizations across industries. Our strategy is to be the reinvention partner of choice for our clients and lead in the safe, widespread adoption of AI, and to be the most client-focused, AI-enabled, great place to work in the world. We bring together the talent of our approximately 799,000 people with proprietary assets and platforms, deep process and industry expertise, and leading ecosystem relationships to deliver end-to-end solutions and measurable outcomes at scale. Through our Reinvention Services, we offer broad expertise across Cybersecurity, Digital Core, Finance, Industry and Enterprise, Song, Supply Chain and Engineering, and Talent, with advanced capabilities in AI and Data, Industry and Process, and Technology. We serve approximately 9,000 clients and generated approximately $70 billion in FY25 revenue. Visit us at accenture.com.

About Google Cloud

Google Cloud offers a powerful, optimized AI stack—including AI infrastructure, leading models like Gemini, data management capabilities, multicloud security solutions, developer tools and platform, as well as agents and applications—that enables organizations to transform their business for the Agentic Era. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner.

SOURCE Google Cloud

Share this article

ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against ARS Pharmaceuticals, Inc. ("ARS" or "the Company") (NASDAQ: SPRY) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of SPRY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: March 9, 2026 to June 24, 2026

DEADLINE: October 5, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. ARS knew its timeline for CVS Caremark formulary and coverage approval decisions for neffy faced issues. The Company's commercialization plans would be impacted by this delay. Based on these facts, ARS's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's David Schwartz is a founding partner of Schall Brown & Schwartz LLP, and his primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

SOURCE DJS Law Group LLP

Share this article

UWM Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UWMC

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against UWM Holdings Corporation ("UWM" or "the Company") (NYSE: UWMC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of UWMC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: March 9, 2026 to August 5, 2026

DEADLINE: October 13, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. UWM created an excess hedging risk by deviating from its strategy of not hedging its mortgage servicing rights. Based on these facts, UWM's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

SOURCE DJS Law Group LLP

Share this article